Literature DB >> 15141600

Pharmacoeconomics.

Jaya Ahuja1, Madhur Gupta, Ajay Kumar Gupta, Kamlesh Kohli.   

Abstract

Pharmacoeconomics focuses on the costs and benefits of drug therapy and pharmacoeconomic evaluations provide a basis for resource allocation and utilization. It is increasingly becoming important for health policy decision-making. A pharmacoeconomic evaluation may be conducted as an economic assessment incorporated into clinical trials. Such trials should compare the new drug/procedure with an older drug or existing intervention. Four techniques are used for economic evaluation, namely, cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis. The choice of the evaluation method depends on the nature of outcomes and the context in which the choices need to be made. Pharmacoeconomics is a young science that will improve with application. Its need is undeniable, especially in developing countries.

Mesh:

Year:  2004        PMID: 15141600

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  6 in total

1.  Transparency in economic evaluations.

Authors:  Suzanne Hill
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital.

Authors:  Aylin Acar Sancar; Selen Yegenoglu; Robin de Vries; Maarten J Postma; Nimet Simsek; Petros Pechlivanoglou; Serhat Unal
Journal:  Pharm World Sci       Date:  2008-09-21

3.  The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.

Authors:  Christine Y Lu; Kenneth M Williams; Richard O Day
Journal:  Aust New Zealand Health Policy       Date:  2007-03-01

4.  Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India.

Authors:  Divya Mishra; Sunita R Nair
Journal:  Perspect Clin Res       Date:  2015 Jan-Mar

Review 5.  Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.

Authors:  Abdulaziz Ibrahim Alzarea; Yusra Habib Khan; Abdullah Salah Alanazi; Muhammad Hammad Butt; Ziyad Saeed Almalki; Abdullah K AlAhmari; Saud Alsahali; Tauqeer Hussain Mallhi
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

Review 6.  The role of pharmacoeconomics in current Indian healthcare system.

Authors:  Akram Ahmad; Isha Patel; Sundararajan Parimilakrishnan; Guru Prasad Mohanta; HaeChung Chung; Jongwha Chang
Journal:  J Res Pharm Pract       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.